ALKS FY 2024 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena

ALKSAlkermes plc

$5B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.6B-6.4% YoY

Gross Profit

$1.3B84.2% margin

Operating Income

$421M27.0% margin

Net Income

$367M23.6% margin

EPS (Diluted)

$2.17

Cash Flow

Operating Cash Flow

$439M

Free Cash Flow

$406M

Stock-Based Comp.

$97M

Balance Sheet

Total Assets

$2.1B

Total Liabilities

$591M

Stockholders' Equity

$1.5B

Cash & Equivalents

$291M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.6B	$1.7B	-6.4%
Gross Profit	$1.3B	$1.4B	-7.0%
Operating Income	$421M	$414M	+1.6%
Net Income	$367M	$356M	+3.2%